Immunovant, Inc.
NASDAQ:IMVT
29.93 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 635.365 | 376.532 | 493.817 | 400.146 | 100.571 | 0.325 | 0 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 635.365 | 376.532 | 493.817 | 400.146 | 100.571 | 0.325 | 0 |
| Net Receivables
| 5.503 | 0.885 | 12.861 | 0.548 | 3.045 | 0 | 0 |
| Inventory
| 0 | -0 | -0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 24.902 | 26.916 | 6.253 | 8.312 | 5.46 | 0.006 | 0.113 |
| Total Current Assets
| 665.77 | 404.333 | 512.931 | 409.006 | 109.076 | 0.325 | 0.113 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 0.595 | 1.505 | 2.633 | 3.483 | 0.065 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0.347 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0.246 | 0.08 | 0 |
| Total Non-Current Assets
| 0.942 | 1.505 | 2.633 | 3.483 | 0.311 | 0.08 | 0 |
| Total Assets
| 666.712 | 405.838 | 515.564 | 412.489 | 109.387 | 0.405 | 0.113 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 7.155 | 1.353 | 18.629 | 2.432 | 1.19 | 0 | 1.136 |
| Short Term Debt
| 0.138 | 1.173 | 1.145 | 1.179 | 3.19 | 0.3 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | -3.19 | -0 | 0 |
| Other Current Liabilities
| 41.315 | 40.771 | 24.746 | 15.16 | 14.128 | 0.08 | 0.474 |
| Total Current Liabilities
| 48.608 | 43.297 | 44.52 | 18.771 | 15.318 | 0.38 | 1.61 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0 | 0.047 | 1.219 | 2.238 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0.347 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 14.128 | 0 | 0 |
| Total Non-Current Liabilities
| 0.347 | 0.047 | 1.219 | 2.238 | 14.128 | 0.3 | 0 |
| Total Liabilities
| 48.955 | 43.344 | 45.739 | 21.009 | 15.318 | 0.38 | 1.61 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.014 | 0.013 | 0.012 | 0.01 | 0.005 | 0 | 0 |
| Retained Earnings
| -825.683 | -566.347 | -355.387 | -198.657 | -91.226 | -0 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 1.908 | 0.852 | 0.404 | -0.298 | -0.016 | 0.343 | -1.497 |
| Other Total Stockholders Equity
| 1,441.518 | 927.976 | 824.796 | 590.425 | 185.306 | -0.318 | 0 |
| Total Shareholders Equity
| 617.757 | 362.494 | 469.825 | 391.48 | 94.069 | 0.025 | -1.497 |
| Total Equity
| 617.757 | 362.494 | 469.825 | 391.48 | 94.069 | 0.025 | -1.497 |
| Total Liabilities & Shareholders Equity
| 666.712 | 405.838 | 515.564 | 412.489 | 109.387 | 0.405 | 0.113 |